Search

Author/Creator Daryani, Vinay M.

1. A phase II trial evaluating the feasibility of adding bevacizumab to standard osteosarcoma therapy. Issue 7 (3rd July 2017)

Authors:
Navid, Fariba; Santana, Victor M.; Neel, Michael; McCarville, M. Beth; Shulkin, Barry L.; Wu, Jianrong; Billups, Catherine A.; Mao, Shenghua; Daryani, Vinay M.; Stewart, Clinton F.; Kunkel, Michelle; Smith, Wendene; Ward, Deborah; Pappo, Alberto S.; Bahrami, Armita; Loeb, David M.; Reikes Willert...
Journal:
International journal of cancer
Issue:
Volume 141:Issue 7(2017:Oct. 01)
Page Start:
1469
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Determination of methotrexate, 7-hydroxymethotrexate, and 2, 4-diamino-N10-methylpteroic acid by LC–MS/MS in plasma and cerebrospinal fluid and application in a pharmacokinetic analysis of high-dose methotrexate. Issue 16 (1st October 2016)

Authors:
Roberts, Michael S.; Selvo, Nicholas S.; Roberts, Jessica K.; Daryani, Vinay M.; Owens, Thandranese S.; Harstead, K. Elaine; Gajjar, Amar; Stewart, Clinton F.
Journal:
Journal of liquid chromatography & related technologies
Issue:
Volume 39:Issue 16(2016)
Page Start:
745
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Feasibility of Pegylated Interferon in Children and Young Adults With Resected High‐Risk Melanoma. Issue 7 (1st April 2016)

Authors:
Navid, Fariba; Herzog, Cynthia E.; Sandoval, John; Daryani, Vinay M.; Stewart, Clinton F.; Gattuso, Jami; Mandrell, Belinda; Phipps, Sean; Chemaitilly, Wassim; Sykes, April; Davidoff, Andrew M.; Shulkin, Barry L.; Bahrami, Armita; Furman, Wayne L.; Mao, Shenghua; Wu, Jianrong; Schiff, Deborah; Ra...
Journal:
Pediatric blood & cancer
Issue:
Volume 63:Issue 7(2016)
Page Start:
1207
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Pharmacokinetic basis for dosing high‐dose methotrexate in infants and young children with malignant brain tumours. Issue 2 (8th January 2020)

Authors:
Panetta, John C.; Roberts, Jessica K.; Huang, Jie; Lin, Tong; Daryani, Vinay M.; Harstead, K. Elaine; Patel, Yogesh T.; Onar‐Thomas, Arzu; Campagne, Olivia; Ward, Deborah A.; Broniscer, Alberto; Robinson, Giles; Gajjar, Amar; Stewart, Clinton F.
Journal:
British journal of clinical pharmacology
Issue:
Volume 86:Issue 2(2020)
Page Start:
362
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Phase I expansion cohort to evaluate the combination of bevacizumab, sorafenib and low-dose cyclophosphamide in children and young adults with refractory or recurrent solid tumours. (June 2020)

Authors:
Federico, Sara M.; Caldwell, Kenneth J.; McCarville, Mary B.; Daryani, Vinay M.; Stewart, Clinton F.; Mao, Shenghua; Wu, Jianrong; Davidoff, Andrew M.; Santana, Victor M.; Furman, Wayne L.; Pappo, Alberto S.; Navid, Fariba
Journal:
European journal of cancer
Issue:
Volume 132(2020)
Page Start:
35
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Phase II evaluation of sunitinib in the treatment of recurrent or refractory high‐grade glioma or ependymoma in children: a children's Oncology Group Study ACNS1021. (25th April 2016)

Authors:
Wetmore, Cynthia; Daryani, Vinay M.; Billups, Catherine A.; Boyett, James M.; Leary, Sarah; Tanos, Rachel; Goldsmith, Kelly C.; Stewart, Clinton F.; Blaney, Susan M.; Gajjar, Amar
Journal:
Cancer medicine
Issue:
Volume 5:Number 7(2016:Jul.)
Page Start:
1416
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗